Correction: Copy Number Variation of KIR Genes Influences HIV-1 Control.

Correction: Copy Number Variation of KIR Genes Influences HIV-1 Control.

[This corrects the article on p. e1001208 in vol. 9.].

Dettagli Bibliografici
Autori principali:	Pelak, K, Need, A, Fellay, J, Shianna, K, Feng, S, Urban, T, Ge, D, De Luca, A, Martinez-Picado, J, Wolinsky, S, Martinson, J, Jamieson, B, Bream, J, Martin, M, Borrow, P, Letvin, N, McMichael, A, Haynes, B, Telenti, A, Carrington, M, Goldstein, D, Alter, G, on behalf of NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI)
Natura:	Journal article
Lingua:	English
Pubblicazione:	2011

Documenti analoghi

Copy number variation of KIR genes influences HIV-1 control
di: Pelak, K, et al.
Pubblicazione: (2011)

CCL3L1 and HIV/AIDS susceptibility.
di: Urban, T, et al.
Pubblicazione: (2009)

HLA class I and KIR genes do not protect against HIV type 1 infection in highly exposed uninfected individuals with hemophilia A.
di: Vince, N, et al.
Pubblicazione: (2014)

Common genetic variation and the control of HIV-1 in humans.
di: Fellay, J, et al.
Pubblicazione: (2009)

Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population.
di: Petrovski, S, et al.
Pubblicazione: (2011)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
di: Wong-Baeza, I, et al.
Pubblicazione: (2011)

The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression.
di: Walley, N, et al.
Pubblicazione: (2009)

KIR-HLA footprints and NK cell-mediated recognition of HIV-1
di: Thobakgale, C, et al.
Pubblicazione: (2012)

Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
di: Chrissy H Roberts, et al.
Pubblicazione: (2014-03-01)

No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis.
di: McCappin, J, et al.
Pubblicazione: (2010)

The genetics of HIV resistance in exposed uninfected Haemophilia A patients: an update on the CHAVI 014 protocol
di: Dorrell, L, et al.
Pubblicazione: (2010)

Nomenclature for the KIR of non-human species
di: Robinson, J, et al.
Pubblicazione: (2018)

Lack of association of KIR3DL1 or KIR3DS1 with ankylosing spondylitis in a UK population
di: Harvey, D, et al.
Pubblicazione: (2007)

Identification of domains that control the heteromeric assembly of Kir5.1/Kir4.0 potassium channels.
di: Konstas, A, et al.
Pubblicazione: (2003)

Imputation of KIR Types from SNP Variation Data.
di: Vukcevic, D, et al.
Pubblicazione: (2015)

Differential pH sensitivity of Kir4.1 and Kir4.2 and their modulation by heteropolymerisation with Kir5.1
di: Pessia, M, et al.
Pubblicazione: (2001)

Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.
di: Hiby, SE, et al.
Pubblicazione: (2010)

Inhibitory effect of terfenadine on Kir2.1 and Kir2.3 channels
di: Delgado-Ramírez Mayra, et al.
Pubblicazione: (2021-06-01)

Differential pH sensitivity of Kir4.1 and Kir4.2 potassium channels and their modulation by heteropolymerisation with Kir5.1.
di: Pessia, M, et al.
Pubblicazione: (2001)

KIR2DL2, KIR2DL5A and KIR2DL5B genes induce susceptibility to dengue virus infection while KIR3DL3 and KIR2DS5 confers protection
di: Aziz Sidi Aristide TAPSOBA, et al.
Pubblicazione: (2022-10-01)

KIR2DL2, KIR2DL5A and KIR2DL5B genes induce susceptibility to dengue virus infection while KIR3DL3 and KIR2DS5 confers protection
di: Aziz Sidi Aristide TAPSOBA, et al.
Pubblicazione: (2022-10-01)

Crystal structure of the potassium channel KirBac1.1 in the closed state.
di: Kuo, A, et al.
Pubblicazione: (2003)

Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.
di: Tammaro, P, et al.
Pubblicazione: (2005)

A whole-genome association study of major determinants for host control of HIV-1.
di: Fellay, J, et al.
Pubblicazione: (2007)

No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis (vol 75, pg 68, 2009)
di: McCappin, J, et al.
Pubblicazione: (2011)

Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes.
di: Gillespie, G, et al.
Pubblicazione: (2007)

Kir5.1 underlies long-lived subconductance levels in heteromeric Kir4.1/Kir5.1 channels from Xenopus tropicalis.
di: Shang, L, et al.
Pubblicazione: (2009)

Identification of mutations in Kir5.1 which affect time-dependent activation of heteromeric Kir4.1/Kir5.1 potassium channels
di: Tucker, S, et al.
Pubblicazione: (2002)

Inhibition of Cardiac Kir Current (IK1) by Protein Kinase C Critically Depends on PKCβ and Kir2.2.
di: Daniel Scherer, et al.
Pubblicazione: (2016-01-01)

Conservation, extensive heterozygosity, and convergence of signaling potential all indicate a critical role for KIR3DL3 in higher primates
di: Leaton, L, et al.
Pubblicazione: (2019)

Glimepiride block of Kir6.2/SUR1 Kir6.2/SUR2A and Kir6.2/SUR2A and Kir6.2/SUR2B K-ATP channels.
di: Ashcroft, F, et al.
Pubblicazione: (2001)

Permeation and gating in KirBac: Molecular dynamics simulations
di: Grottesi, A, et al.
Pubblicazione: (2004)

Potassium Channel KIR4.1-Specific Antibodies and Acquired Demyelinating Disease
di: J Gordon Millichap, et al.
Pubblicazione: (2014-04-01)

INWARDLY RECTIFYING K+ CURRENTS IN OOCYTES CO-EXPRESSING KIR3.1 AND KIR3.2
di: Ammala, C, et al.
Pubblicazione: (1995)

Control of pH and PIP2 gating in heteromeric Kir4.1/Kir5.1 channels by H-Bonding at the helix-bundle crossing.
di: Rapedius, M, et al.
Pubblicazione: (2007)

Th17 cells expressing KIR3DL2+are increased in ankylosing spondylitis
di: Ridley, A, et al.
Pubblicazione: (2010)

Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
di: Proks, P, et al.
Pubblicazione: (2004)

THE ROLE OF HLA-B27 KIR3DL2 INTERACTIONS IN THE PATHOGENESIS OF SPONDYLOARTHRITIS
di: Kollnberger, S, et al.
Pubblicazione: (2012)

Molecular basis of Kir6.2 mutations causing neonatal diabetes and neonatal diabetes with neurological features
di: Proks, P, et al.
Pubblicazione: (2005)

HLA-B*14:02-Restricted Env-Specific CD8+ T-cell activity has highly potent antiviral efficacy associated with immune control of HIV infection
di: Leitman, E, et al.
Pubblicazione: (2017)